Natixis Advisors, L.P. Viatris Inc Transaction History
Natixis Advisors, L.P.
- $63 Billion
- Q2 2025
A detailed history of Natixis Advisors, L.P. transactions in Viatris Inc stock. As of the latest transaction made, Natixis Advisors, L.P. holds 148,546 shares of VTRS stock, worth $1.51 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
148,546
Previous 319,196
53.46%
Holding current value
$1.51 Million
Previous $2.78 Million
52.3%
% of portfolio
0.0%
Previous 0.01%
Shares
19 transactions
Others Institutions Holding VTRS
# of Institutions
1,130Shares Held
983MCall Options Held
7.62MPut Options Held
2.97M-
Vanguard Group Inc Valley Forge, PA145MShares$1.47 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$940 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD78.8MShares$799 Million0.08% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az66.4MShares$673 Million3.26% of portfolio
-
State Street Corp Boston, MA55.3MShares$561 Million0.02% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $12.3B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...